A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia
Clinical trial NCT04230473 · COMPLETED
Trial details
- NCT number
- NCT04230473
- Sponsor
- Juventas Cell Therapy Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-13
- Primary completion
- 2020-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.